Is there a role for erythropoietin in cardiovascular disease? - Wikidata - wikimedia - TriplyDB

Is there a role for erythropoietin in cardiovascular disease?

Is there a role for erythropoietin in cardiovascular disease?

http://www.wikidata.org/entity/Q37661050

about

Chronic administration of small nonerythropoietic peptide sequence of erythropoietin effectively ameliorates the progression of postmyocardial infarction-dilated cardiomyopathy.Did clinical trials in which erythropoietin failed to reduce acute myocardial infarct size miss a narrow therapeutic window?Wnt1, FoxO3a, and NF-kappaB oversee microglial integrity and activation during oxidant stress.Wnt1 neuroprotection translates into improved neurological function during oxidant stress and cerebral ischemia through AKT1 and mitochondrial apoptotic pathways.The use of genes for performance enhancement: doping or therapy?Acute hemodynamic effects of erythropoietin do not mediate its cardioprotective properties.Troponin T release is associated with silent myocardial ischaemia in black men: The SABPA Study.Histopathological study of erythropoietin protective effect on carbon monoxide-induced cardiotoxicity in rat.Impact of an interleukin-1 receptor antagonist and erythropoietin on experimental myocardial ischemia/reperfusion injury

P2860

Q30539892-334D22D6-453F-4E5E-AA4C-B61748AC9930 Q31056941-2801FE30-0DEF-4AF0-AE32-5F66C333C06E Q33945459-99688A19-4BE2-4080-AEB6-91B8D3A1DAD0 Q34185844-0F500B3F-6522-46AF-B4B3-94CAF847D230 Q34227757-CB8667C6-4722-4F07-BCA0-668BB454B614 Q36425514-579230C1-B8CC-439B-A419-B8E7521C361F Q46236288-F63F7539-BBA8-4D81-9B00-DA5DD755D700 Q47142543-8F51D7C2-173D-4A1B-93BC-9F328ED78753 Q58915021-BA86BADE-361B-4345-AEB3-5E1678B184E3

P2860

Is there a role for erythropoietin in cardiovascular disease?

http://www.wikidata.org/entity/Q37661050

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Is there a role for erythropoietin in cardiovascular disease?

@en

Is there a role for erythropoietin in cardiovascular disease?

@nl

type

label

Is there a role for erythropoietin in cardiovascular disease?

@en

Is there a role for erythropoietin in cardiovascular disease?

@nl

prefLabel

Is there a role for erythropoietin in cardiovascular disease?

@en

Is there a role for erythropoietin in cardiovascular disease?

@nl

P1433

Q37661050-3E10EFBB-C360-4CE1-A25B-29FCE19EA9BD

P1476

Q37661050-835F15E7-A917-464C-938B-E60D3F5CF73E

P2093

Q37661050-0342D8FD-9795-4FD9-A4D2-6ED512DF1045

Q37661050-271A5FBC-8352-425A-B2AB-082A7D9C0825

Q37661050-CC859918-7DC8-4B8F-8A23-0CAF9E35FB04

Q37661050-F6884F3F-0C6F-418F-8953-B0378D577CDC

P2860

Q37661050-000FA7A3-BCD6-4474-927E-4F0986B6C5AE

Q37661050-043E454B-FA9E-4006-A926-91C248312CCA

Q37661050-0760F313-F11D-476C-A35E-6549434AD426

Q37661050-0868B5E6-5BE5-475A-AB4A-3D738B03CF43

Q37661050-0BC84E13-4733-41E3-A1D2-25A5AB080B37

Q37661050-1279B25F-531C-42DF-B554-8965BC518CE6

Q37661050-172D9E95-3BE2-48D3-8EB4-12EB6BA3192A

Q37661050-1DA23890-772C-4C2C-B027-FC80AA9E0730

Q37661050-1E05C1C6-4343-4C73-9DFA-52698150D01B

Q37661050-22503938-485B-4C7A-A8BA-1D35DBE9D7D6

P304

Q37661050-C7B6BBB1-2E74-4E05-896E-A77D1E78E24D

P31

Q37661050-F96B6F87-7F2B-4BE2-A747-3D6FEE9D5197

P356

Q37661050-1403EF1F-2341-470E-9409-9C4827C63AAE

P407

Q37661050-89093206-BF55-487A-87A5-FBB69EA676F0

P433

Q37661050-66E8B005-C621-4CA5-A015-E3B517E4A442

P478

Q37661050-F67698D5-3F81-48E6-A177-C727CB49A3AB

P50

Q37661050-4BCEB88E-563B-49B1-81F3-76C32524E7EB

P577

Q37661050-1045595F-0933-4C7E-AD15-DD7122D83BEB

P698

Q37661050-9CF944C6-1400-4606-BEAD-242AF1146308

P921

Q37661050-C76FD852-32D0-45C4-B26E-D7622E807291

Q37661050-DA8882F6-A7AC-4847-97DE-93F014E87EC8

P356

14712590903547819

P1433

Expert Opinion on Biological Therapy

P1476

Is there a role for erythropoietin in cardiovascular disease?

@en

P2093

Alexandros Briasoulis

http://www.w3.org/2001/XMLSchema#string

Dimitris Tousoulis

http://www.w3.org/2001/XMLSchema#string

Georgia Vogiatzi

http://www.w3.org/2001/XMLSchema#string

Nikolaos Papageorgiou

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of recombinant human erythropoietin on antiplatelet action of aspirin and clopidogrel in healthy subjects: results of a double-blind, placebo-controlled randomized trial

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor

Effect of 1-week treatment with erythropoietin on the vascular endothelial function in anaesthetized rabbits

AKT1 drives endothelial cell membrane asymmetry and microglial activation through Bcl-xL and caspase 1, 3, and 9

Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats.

Erythropoietin regulates vascular smooth muscle cell apoptosis by a phosphatidylinositol 3 kinase-dependent pathway.

Erythropoietin and VEGF exhibit equal angiogenic potential.

Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients.

Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis.

P304

251-264

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712590903547819

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Christodoulos Stefanadis

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20028188

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease